Mathias Schmidt

2.7k total citations
59 papers, 2.2k citations indexed

About

Mathias Schmidt is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Mathias Schmidt has authored 59 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 20 papers in Oncology and 18 papers in Immunology. Recurrent topics in Mathias Schmidt's work include Toxin Mechanisms and Immunotoxins (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Microtubule and mitosis dynamics (10 papers). Mathias Schmidt is often cited by papers focused on Toxin Mechanisms and Immunotoxins (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Microtubule and mitosis dynamics (10 papers). Mathias Schmidt collaborates with scholars based in Germany, United States and Switzerland. Mathias Schmidt's co-authors include Holger Bastians, Zhen Fan, Winfried S. Wels, Bolin Liu, John Mendelsohn, Yang Lü, Volker Gekeler, Carsten Denkert, Wilko Weichert and Manfred Dietel and has published in prestigious journals such as Blood, Oncogene and Journal of Medicinal Chemistry.

In The Last Decade

Mathias Schmidt

58 papers receiving 2.2k citations

Peers

Countries citing papers authored by Mathias Schmidt

Since Specialization

Citations

This map shows the geographic impact of Mathias Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Schmidt more than expected).

Fields of papers citing papers by Mathias Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Schmidt. The network helps show where Mathias Schmidt may publish in the future.

Co-authorship network of co-authors of Mathias Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Schmidt. A scholar is included among the top collaborators of Mathias Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Schmidt. Mathias Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor cells that resist neutrophil anticancer cytotoxicity acquire a prometastatic and innate immune escape phenotype 2025 ·Cellular and Molecular Immunology ·(unknown), (unknown), Bettina Budeus, (unknown), Claudia A. Dumitru, Mathias Schmidt, (unknown), Sebastián Vollmer, Eva-Maria Hanschmann, Maike Busch, Jan Kehrmann, Stephan Lang, Nicole Dünker, Timon Hussain, Sven Brandau	1
2	Electrolyte imbalance causes suppression of NK and T cell effector function in malignant ascites 2023 ·Journal of Experimental & Clinical Cancer Research ·(unknown), Mathias Schmidt, Bernd Wagner, Denise Zwanziger, Rainer Kimmig, Lothar Volbracht, Sven Brandau, Nina Gottschalk	11
3	Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations 2020 ·Cancers ·Brigitte Royer‐Pokora, Maike Busch, (unknown), Mathias Schmidt, Manfred Beier, (unknown), Hölger Thiele, Jaume Mora	7
4	Krankheitsfreies Überleben bei papillärem und follikulärem Schilddrüsenkarzinom 2013 ·Nuklearmedizin - NuclearMedicine ·(unknown), Martin Hellmich, Markus Dietlein, Carsten Kobe, H Schicha, Mathias Schmidt	4
5	Calcitonin-Screening bei Patienten mit Schilddrüsenknoten – Diagnostische Bedeutung 2012 ·Nuklearmedizin - NuclearMedicine ·(unknown), Carsten Kobe, Mathias Schmidt, Deniz Kahraman, Gebhart Malchau, Michael Faust, H Schicha, Markus Dietlein	4
6	Cell cycle‐dependent cytotoxicity and mitotic spindle checkpoint dependency of investigational and approved antimitotic agents 2011 ·International Journal of Cancer ·(unknown), Alexander Bürkle, (unknown), Thomas M. Maier, Mathias Schmidt	7
7	Should all patients with thyroid nodules ≥ 1 cm undergo fine-needle aspiration biopsy? 2009 ·Nuklearmedizin - NuclearMedicine ·Martin Hellmich, Walter Lehmacher, W. Eschner, Mathias Schmidt, Carsten Kobe, (unknown), (unknown), (unknown)	19
8	Expression patterns of polo‐like kinase 1 in human gastric cancer 2006 ·Cancer Science ·Wilko Weichert, (unknown), Mathias Schmidt, Volker Gekeler, Aurelia Noske, Silvia Niesporek, Ann‐Christin Buckendahl, Manfred Dietel, Carsten Denkert	42
9	Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications 2005 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Wilko Weichert, Glen Kristiansen, Klaus‐Jürgen Winzer, Mathias Schmidt, Volker Gekeler, Aurelia Noske, B. Müller, Silvia Niesporek, Manfred Dietel, Carsten Denkert	125
10	Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells 2004 ·British Journal of Cancer ·(unknown), Thomas Beckers, Mathias Schmidt	48
11	Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma 2004 ·British Journal of Cancer ·Wilko Weichert, Carsten Denkert, Mathias Schmidt, Volker Gekeler, Georg Wolf, Martin Köbel, Manfred Dietel, S. Hauptmann	147
12	Polo‐like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades 2004 ·The Prostate ·Wilko Weichert, Mathias Schmidt, Volker Gekeler, Carsten Denkert, Carsten Stephan, Klaus Jung, Stefan A. Loening, Manfred Dietel, Glen Kristiansen	158
13	2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors. 2002 ·PubMed ·Thomas Beckers, Thomas Reissmann, Mathias Schmidt, Angelika M. Burger, Heinz H. Fiebig, U. Vanhoefer, Herwig Pongratz, (unknown), Jörg Hockemeyer, M Frieser, Siavosh Mahboobi	42
14	A novel form of constitutively active farnesylated Akt1 prevents mammary epithelial cells from anoikis and suppresses chemotherapy-induced apoptosis 2002 ·British Journal of Cancer ·Mathias Schmidt, (unknown), Thomas Beckers	41
15	Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells 2001 ·Oncogene ·Mathias Schmidt, Zhen Fan	35
16	Nasal Epithelial Permeation of Thymotrinan (TP3) Versus Thymocartin (TP4): Competitive Metabolism and Self-Enhancement 2000 ·Pharmaceutical Research ·Mathias Schmidt, Werner Rubas, (unknown)	7
17	Differential modulation of paclitaxel-mediated apoptosis by p21Waf1 and p27Kip1 2000 ·Oncogene ·Mathias Schmidt, Yang Lü, Bolin Liu, Min Fang, John Mendelsohn, Zhen Fan	60
18	Validation of Excised Bovine Nasal Mucosa as In Vitro Model to Study Drug Transport and Metabolic Pathways in Nasal Epithelium‡‡Data adopted from yet unpublished parts of the Ph.D. theses of Günter Ditzinger, Steffen Lang, and M. Christiane Schmidt 2000 ·Journal of Pharmaceutical Sciences ·Mathias Schmidt, Daniel Simmen, Monika Hilbe, (unknown), (unknown), Jürgen Sandow, Steffen Lang, Werner Rubas, Hans P. Merkle	58
19	Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells. 1998 ·PubMed ·(unknown), Mathias Schmidt, (unknown), Uwe Altenschmidt, Elisabeth Stöcklin, Winfried S. Wels, Bernd Groner	43
20	Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF α 1996 ·British Journal of Cancer ·Mathias Schmidt, Winfried S. Wels	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact